AusQuest surges 10% on promising samples from Parcoy

|

Published 11-MAY-2020 14:57 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

AusQuest Limited (ASX:AQD) has kicked off the week with some promising newsflow from its operations in Peru, and this comes on the back of last Thursday’s announcement that the group had identified the potential for both base metals and rare earth elements (REE) in the Fraser Range Province of Western Australia following a review of recent and historical drilling at its Balladonia Project - more on that later.

On Monday morning the company’s shares opened 10% higher after management announced that 24 of the rock chip samples collected at its Parcoy prospect contained in excess of 1% copper.

Many of these samples occur in andesitic volcanics, similar to the volcanics that contain copper mineralisation at the company’s Cerro de Fierro Project, located approximately 50 kilometres to the south-east, suggesting similar iron-oxide copper-gold mineralisation may be present at Parcoy.

Anomalous copper values within the volcanics are associated with a range of indicator elements, defining at least two priority target areas along the prospective north-west trending structure, each covering several square kilometres in size.

Management has completed base-line environmental and archaeological surveys and it is in the process of submitting drill permit applications to government for the preparation of twenty drill pads in the area.

Final drilling approval for Parcoy is expected during the September quarter of 2020, subject to delays being caused by the COVID-19 pandemic.

Carbonatite activity points to rare earth potential at Telegraph prospect

Results from recent diamond drilling at the Telegraph Prospect, part of AusQuest’s aforementioned Balladonia Project, together with a review of earlier drilling results from the Canterbury prospect, has indicated the possibility of wide-spread carbonatite activity within the project area.

Carbonatites are a type of igneous rock which is a major source of rare earth elements (REE) worldwide.

Assay results from the recent diamond drilling program (four drill-holes for 980 metres) at the Telegraph Prospect have confirmed the presence of a carbonatite intrusion with a layered sovite core beneath the silica-clay alteration intersected by the earlier air-core and reverse circulation (RC) drilling.

A detailed assessment of all geochemical data suggests the source of the base metal anomalism within the silica-clay alteration has not been intersected by the diamond drilling.

The company now believes that base metal mineralisation occurs to the south and east of the current drilling, below the anomalous copper, silver and zinc values that occur within the silica-clay alteration zone near the eastern margin of the target.

Further drilling under the Strategic Alliance Agreement with South32 (ASX: S32) will be considered once all the data have been fully assessed.

Commenting on developments in relation to the Balladonia Project, managing director Graeme Drew said, ‘’The discovery of carbonatite activity within the Balladonia region was an exciting new development for the Fraser Range region which would provide new exploration opportunities for the company.

“It’s important to remember that developing a solid understanding of geological context and what it means for discovery potential only comes from drilling - and drilling activity is still at a really early stage in this region.’’



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X